Maintenance Notice (8:45 AM - 1:00 PM February 22, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | New tool "TCI SpectraViewer" | [Product Highlights] Chemiluminescent Reagents for... | Product Document Searching Made Easy by 2D Code!
Maximum quantity allowed is 999
Please select the quantity
Jumonji Domain-containing Histone Demethylase (JHDM) Inhibitor
No.158(July 2013)
Jumonji domain-containing histone demethylase (JHDM) is an enzyme catalyzing the demethylation of the methylated lysine residue in histone, which regulates the expression of Mdm2 oncogene and p53 anti-oncogene. NCDM-32b (1), developed by Suzuki, Miyata et al., forms NCDM-32 losing a methyl group of the ester moiety by hydrolytic degradation, and shows an inhibitory activity against JMJD2C, a kind of JHDM. NCDM-32 inhibits the growth of HCT116 colon cancer cells with a combination of LSD1 inhibitor.
References
- Design, synthesis, enzyme-Inhibitory activity, and effect on human cancer cells of a novel series of Jumonji domain-containing protein 2 histone demethylase inhibitors
Related Compounds
The prices are subject to change without notice. Please confirm the newest price by our online catalog before placing an order.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.
In addition, sales products changes with areas. Please understand that a product is not available when the product details page is not displayed.